Total Funding
56
62
Total FundingGrant raised
Growth Score 56 in past quarter
-2 pts
Heat Score 62 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
49462
PhagePro is an early-stage biotechnology therapeutics company.
- Andrew Camilli: Co-Founder & Scientific Advisor
- Minimin Yen: Co-Founder & Chief Executive Officer
About the Company
PhagePro is an early-stage biotechnology therapeutics company that develops bacteriophage-based products to help the world's most vulnerable communities.
Women Founded
